A multinational team led by Weill Cornell Medicine investigators developed a test for an HIV strain that disproportionately affects women and will benefit patients around the world.
Cornell researchers have developed a bioelectric device that can detect and classify new variants of coronavirus, and potentially other viruses, such as measles and influenza, to identify those that are most harmful.
ACT for Youth, which promotes adolescent health and well-being in New York state, has been awarded $5 million to help local health departments improve care for youth with special needs.
Cornell inventors are turning visionary ideas into tangible solutions to global challenges. Cornell’s Center for Technology Licensing celebrated their achievements at its inaugural Bearers of Innovation event.
Before a cell commits fully to the process of dividing itself into two new cells, it may ensure the appropriateness of its commitment by staying for many hours – sometimes more than a day – in a reversible intermediate state, according to new research.
TeraPore Technologies, co-founded by Rachel Dorin, Ph.D. ’13, and its novel nanofiltration products are changing how the pharmaceutical industry is reducing risk of harmful virus contamination in biological drugs.
Wildlife experts have developed a regional computer model – and user friendly app – that predicts counties where wildlife managers should target their surveillance of chronic wasting disease in deer.
